WALTHAM, Mass. & LITTLE FALLS, N.J.--(BUSINESS WIRE)--Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and product safety, and Sentrx, a leading provider of technology-enabled services for global drug safety, today announced a partnership that will provide life sciences companies with a sophisticated combination of safety data management and adverse event reporting software, processes and consulting expertise.